|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-3-13
|
|
pubmed:abstractText |
Knowledge of axillary lymph node status is a key aid to staging and prognosis and it represents a guideline for adjuvant therapy in breast cancer. Despite the morbidity it causes, complete axillary dissection was long the mainstay of treatment. Sentinel lymph node biopsy has proved so reliable in the evaluation of node involvement that axillary node dissection is now generally performed when sentinel node biopsy tests negative.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0026-4733
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17353851-Adult,
pubmed-meshheading:17353851-Aged,
pubmed-meshheading:17353851-Aged, 80 and over,
pubmed-meshheading:17353851-Axilla,
pubmed-meshheading:17353851-Breast Neoplasms,
pubmed-meshheading:17353851-Carcinoma, Ductal, Breast,
pubmed-meshheading:17353851-Coloring Agents,
pubmed-meshheading:17353851-Female,
pubmed-meshheading:17353851-Humans,
pubmed-meshheading:17353851-Lymph Node Excision,
pubmed-meshheading:17353851-Lymph Nodes,
pubmed-meshheading:17353851-Middle Aged,
pubmed-meshheading:17353851-Predictive Value of Tests,
pubmed-meshheading:17353851-Radiopharmaceuticals,
pubmed-meshheading:17353851-Retrospective Studies,
pubmed-meshheading:17353851-Sensitivity and Specificity,
pubmed-meshheading:17353851-Sentinel Lymph Node Biopsy,
pubmed-meshheading:17353851-Technetium Tc 99m Aggregated Albumin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
|
|
pubmed:affiliation |
Department of Surgery, Second University of Naples, Naples, Italy.
|
|
pubmed:publicationType |
Journal Article
|
